Blood plasma biomarkers for Alzheimer’s disease: Aβ1–42/1–40 vs. AβX–42/X–40
Author:
Affiliation:
1. Department of Psychiatry and Psychotherapy , University Medical Center, Goettingen, Georg-August-University , Goettingen , Germany
Publisher
Walter de Gruyter GmbH
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Link
https://www.degruyter.com/document/doi/10.1515/cclm-2023-0990/pdf
Reference15 articles.
1. Wojdala, AL, Bellomo, G, Toja, A, Gaetani, L, Parnetti, L, Chiasserini, D. CSF and plasma Abeta42/40 across Alzheimer’s disease continuum: comparison of two ultrasensitive Simoa® assays targeting distinct amyloid regions. Clin Chem Lab Med 2023;62:332–40.https://doi.org/10.1515/cclm-2023-0659
2. Klafki, HW, Morgado, B, Wirths, O, Jahn, O, Bauer, C, Esselmann, H, et al.. Is plasma amyloid-beta 1-42/1-40 a better biomarker for Alzheimer’s disease than AbetaX-42/X-40? Fluids Barriers CNS 2022;19:96. https://doi.org/10.1186/s12987-022-00390-4.
3. Ovod, V, Ramsey, KN, Mawuenyega, KG, Bollinger, JG, Hicks, T, Schneider, T, et al.. Amyloid beta concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimer’s Dementia 2017;13:841–9. https://doi.org/10.1016/j.jalz.2017.06.2266.
4. Roher, AE, Esh, CL, Kokjohn, TA, Castano, EM, Van Vickle, GD, Kalback, WM, et al.. Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer’s disease. Alzheimer’s Dementia 2009;5:18–29. https://doi.org/10.1016/j.jalz.2008.10.004.
5. Keshavan, A, Wellington, H, Chen, Z, Khatun, A, Chapman, M, Hart, M, et al.. Concordance of CSF measures of Alzheimer’s pathology with amyloid PET status in a preclinical cohort: a comparison of Lumipulse and established immunoassays. Alzheimer’s Dementia 2021;13:e12131. https://doi.org/10.1002/dad2.12131.
Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Therapeutic Potential of Melatonin in Alzheimer's Disease: A Comprehensive Review;Current Medicinal Chemistry;2024-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3